ASTRO Virtual Meeting Center

Log-in / Create Account

Session Information

2008 Annual Meeting

Click here to go to the previous page

Difficult Cases in GYN Management

Track : EDU

Program Code: EDU312

Date: Tuesday, September 23, 2008

Time: 11:00 AM to 12:30 PM EST

Duration: 720 Minutes

Location: 107

SPEAKER(S):

Kaled Alektiar, Memorial Sloan-Kettering Cancer Center

Patricia Eifel, Professor of Radiation Oncology, M.D. Anderson Cancer Center

Anuja Jhingran, Associate Professor, M.D. Anderson Cancer Center

Charles Levenback, M.D. Anderson Cancer Center

Dr. Levenback joined The University of Texas M. D. Anderson Cancer Center in 1989 following the completion of his fellowship training in Gynecologic Oncology at Memorial Sloan Kettering Cancer Center in New York City. He is now a Professor and Deputy Chairman in the Department of Gynecologic Oncology and the Medical Director for the Gynecologic Oncology Center. Dr. Levenback is a leader in clinical research regarding the application of sentinel lymph node biopsy in patients with gynecologic cancers. The goal of this surgical technique is to reduce the morbidity of radical surgery for vulvar and cervical cancer while preserving or improving survival. Dr. Levenback has led numerous clinical trials in this area and currently serves as principal investigator for two Gynecologic Oncology Group studies on the validity of sentinel lymph node biopsy. Hs has published many peer-reviewed articles and book chapters on this topic and is the senior editor of Clinical Lymphatic Mapping for Gynecologic Cancers. He has been invited to share his experience with medical audiences throughout the United States and Europe. Dr. Levenback has co-authored 105 articles in peer-reviewed journals including the New England Journal of Medicine, Journal of Clinical Oncology, Obstetrics and Gynecology and The American Journal of Obstetrics and Gynecology. He has written 20 book chapters and co-edited three additional books on gynecologic cancer topics. Dr. Levenback has earned a reputation as a champion for improved patient-physician communication. He has been a guest speaker at The M. D. Anderson Board of Visitors annual meetings, the Volunteer Recognition Luncheon, the Celebrate Solutions Luncheon and received the 2004 Outstanding Patient Educator Award. A busy clinician, Dr. Levenback sees patients with all types of gynecologic cancer and collaborates on numerous clinical trials. He performs laparoscopic surgical procedures in addition to the more traditional �open� abdominal/pelvic surgery. Dr. Levenback is a husband and father of 2 college aged sons. Undergraduate School: B.A., McGill University Montreal, Canada 1979 Medical School: M.D., Mount Sinai School of Medicine New York, NY, 1983 Internship and Residency: Obstetrics/Gynecology, Albert Einstein College of Medicine Bronx, New York 1983-1987 Fellowship: Gynecologic Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, 1987-89 Board Certification: American Board of Obstetrics and Gynecology, 1991 Division of Gynecology Oncology, American Board of Obstetrics and Gynecology, 1994 Years at MDACC: Since 1989 Publications Morris M, Eifel PJ, Lu J, Levenback C, Grigsby PW, Stevens RE, Rotman M, Gershenson DM, Mutch DG: Pelvic Radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer. NEJM 340(15):1137-1143, 1999. Levenback C, Coleman R, Burke TW, Bevers M, Bodurka-Bevers D, Gershenson DM: Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol 83(2):276-281, 2001. Levenback C, Coleman RL, Burke TW, Lin WM Erdman W, Deavers M, Delpassand ES: Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clinic Oncol 20(3):688-693, 2002. Jenkins AD, Ramondetta LM, Sun C, Johnston T, Wolf JK, Bodurka DC, Brown J, Atkinson EN, Levenback C: Pase II trial of capecitabine in advanced or recurrent squamous cell carcinoma of the cervix.

Nina Mayr, M.D, Professor and Chair of Radiation Medicine and Max Morehouse Chair in Cancer Research, Arthur G. James Cancer Hospital and Solove Research Institute, The Ohio State University

LEARNER OUTCOMES:

Discuss controversies regarding the role of surgical staging and post operative radiation therapy in patients with endometrial cancer.
Discuss the management of regional metastases and the role of chemoradiation in patients with lymph node metastases from vulvar cancer.
Discuss the possible role of regional radiation therapy in selected patients with ovarian cancer.
Outline challenges and techniques used in the management of gross regional disease and marginal recurrence in patients with carcinoma of the cervix.